Evidence map›Paper›PMID 19043074›Full record

ArticleNucleic acids research2009

Inhibition of yeast telomerase action by the telomeric ssDNA-binding protein, Cdc13p.

David C Zappulla, Jennifer N Roberts, Karen J Goodrich, Thomas R Cech, Deborah S Wuttke

Open access · goldAbstract read
In one paragraph

Article in Nucleic acids research, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Review
  3. Analysis of Yeast Telomerase by Primer Extension Assays.Methods in molecular biology (Clifton, N.J.) · 2017
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Cdc13 at a crossroads of telomerase action.Frontiers in oncology · 2013
    Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. The telomeric Cdc13 protein interacts directly with the telomerase subunit Est1 to bring it to telomeric DNA ends in vitro.Proceedings of the National Academy of Sciences of the United States of America · 2011
    Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

David C ZappullaHoward Hughes Medical Institute, University of Colorado, Boulder, CO 80309, USA. zappulla@jhu.edu
Jennifer N Roberts
Karen J Goodrich
Thomas R Cech
Deborah S Wuttke
Howard Hughes Medical Institute · USUniversity of Colorado Boulder · US

Funding

Predoctoral Training Molecular BiophysicsT32GM065103 · NIGMS · UNIVERSITY OF COLORADO AT BOULDER · PI FALKE, JOSEPH J · 2002 to 2021
$4.3M
SINGLE STRANDED DNA RECOGNITION IN TELOMERESR01GM059414 · NIGMS · UNIVERSITY OF COLORADO AT BOULDER · PI WUTTKE, DEBORAH S. · 1999 to 2015
$3.7M
Telomerase and Telomeres: Structure, Function/RegulationR01GM028039 · NIGMS · UNIVERSITY OF COLORADO AT BOULDER · PI CECH, THOMAS ROBERT · 1985 to 2009
$2.6M
Investigating Telomerase Mechanism by Exploring the RNAR00GM080400 · NIGMS · JOHNS HOPKINS UNIVERSITY · PI ZAPPULLA, DAVID CLIFFORD · 2008 to 2010
$745k
Investigating Telomerase Mechanism by Exploring the RNAK99GM080400 · NIGMS · UNIVERSITY OF COLORADO · PI ZAPPULLA, DAVID CLIFFORD · 2007 to 2008
$106k
STUDIES OF NUCLEIC ACID STRUCTURE AND REACTIVITYR37GM028039 · NIGMS · UNIVERSITY OF COLORADO AT BOULDER · PI CECH, THOMAS R · 1988 to 1997
–
Howard Hughes Medical InstituteNIGMS NIH HHS GM28039NIGMS NIH HHS GM59414NIGMS NIH HHS K99 GM080400NIGMS NIH HHS K99 GM80400NIGMS NIH HHS R00 GM080400NIGMS NIH HHS R01 GM059414NIGMS NIH HHS T32 GM65103
6 · The paper itself

Abstract

Appropriate control of the chromosome end-replicating enzyme telomerase is crucial for maintaining telomere length and genomic stability. The essential telomeric DNA-binding protein Cdc13p both positively and negatively regulates telomere length in budding yeast. Here we test the effect of purified Cdc13p on telomerase action in vitro. We show that the full-length protein and its DNA-binding domain (DBD) inhibit primer extension by telomerase. This inhibition occurs by competitive blocking of telomerase access to DNA. To further understand the requirements for productive telomerase 3'-end access when Cdc13p or the DBD is bound to a telomerase substrate, we constrained protein binding at various distances from the 3'-end on two sets of increasingly longer oligonucleotides. We find that Cdc13p inhibits the action of telomerase through three distinct biochemical modes, including inhibiting telomerase even when a significant tail is available, representing a novel 'action at a distance' inhibitory activity. Thus, while yeast Cdc13p exhibits the same general activity as human POT1, providing an off switch for telomerase when bound near the 3'-end, there are significant mechanistic differences in the ways telomere end-binding proteins inhibit telomerase action.

Indexed as

Nuclease Protection AssaysProtein Structure, TertiarySaccharomyces cerevisiaeSaccharomyces cerevisiae ProteinsTelomeraseTelomereTelomere-Binding ProteinsCdc13 protein, S cerevisiaeSaccharomyces cerevisiae ProteinsTelomeraseTelomere-Binding Proteins

Identifiers

PMID19043074
PMCPMC2632905
OpenAlexW2087895851

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.